- •Contents
- •General Introduction
- •Objectives
- •Anatomy
- •Eyelids
- •Conjunctiva
- •Lacrimal Functional Unit
- •The Tear Film
- •Cornea
- •Sclera
- •2 Examination Techniques for the External Eye and Cornea
- •Evaluation of Vision in the Patient With an Abnormal Cornea
- •External Examination
- •Slit-Lamp Biomicroscopy
- •Direct Illumination Methods
- •Indirect Illumination Methods
- •Clinical Use
- •Stains
- •Fluorescein
- •Rose Bengal and Lissamine Green
- •Evaluation of the Tear Film and Tests of Tear Production
- •Tear Composition Assays
- •Imaging Technologies
- •Impression Cytology
- •Corneal Pachymetry
- •Measurement of Corneal Biomechanics
- •Measurement of Corneal Curvature
- •Zones of the Cornea
- •Shape, Curvature, and Power
- •Keratometry
- •Computerized Corneal Topography
- •Corneal Tomography
- •Indications
- •Ultrasound Biomicroscopy
- •Anterior Segment Optical Coherence Tomography
- •Confocal Microscopy
- •External and Slit-Lamp Photography
- •Specular Microscopy
- •Anterior Segment Fluorescein Angiography
- •Esthesiometry
- •Retinoscopy
- •3 Clinical Approach to Ocular Surface Disorders
- •Common Clinical Findings
- •Conjunctival Signs
- •Corneal Signs
- •Clinical Approach to Dry Eye
- •Mechanisms of Dry Eye
- •Aqueous Tear Deficiency
- •Evaporative Dry Eye
- •Treatment of Dry Eye
- •Rosacea
- •Seborrheic Blepharitis
- •Staphylococcal Blepharitis
- •Hordeola and Chalazia
- •Exposure Keratopathy
- •Floppy Eyelid Syndrome
- •Superior Limbic Keratoconjunctivitis
- •Recurrent Corneal Erosion
- •Neurotrophic Keratopathy and Persistent Corneal Epithelial Defects
- •Trichiasis and Distichiasis
- •Factitious Ocular Surface Disorders
- •Dellen
- •Limbal Stem Cell Deficiency
- •Sjögren Syndrome
- •Ichthyosis
- •Ectodermal Dysplasia
- •Xeroderma Pigmentosum
- •Vitamin A Deficiency
- •4 Infectious Diseases of the External Eye: Basic Concepts and Viral Infections
- •Defense Mechanisms of the External Eye
- •Normal Ocular Flora
- •Pathogenesis of Ocular Infections
- •Virulence
- •Inoculum
- •Host Defense
- •Ocular Microbiology
- •Diagnostic Laboratory Techniques
- •Specimen Collection
- •Staining Methods
- •Virology and Viral Infections
- •DNA Viruses: Herpesviruses
- •Herpes Simplex Eye Diseases
- •Varicella-Zoster Virus Dermatoblepharitis, Conjunctivitis, and Keratitis
- •Epstein-Barr Virus Dacryoadenitis, Conjunctivitis, and Keratitis
- •Cytomegalovirus Keratitis and Anterior Uveitis
- •DNA Viruses: Adenoviruses
- •DNA Viruses: Poxviruses
- •Molluscum Contagiosum
- •Vaccinia
- •DNA Viruses: Papovaviruses
- •RNA Viruses
- •Bacteriology
- •Gram-positive Cocci
- •Gram-negative Cocci
- •Gram-positive Rods
- •Gram-negative Rods
- •Gram-positive Filaments
- •Chlamydia Species
- •Spirochetes
- •Mycology
- •Yeasts
- •Septate Filamentous Fungi
- •Nonseptate Filamentous Fungi
- •Parasitology
- •Protozoa
- •Helminths
- •Arthropods
- •Prions
- •Staphylococcal Blepharitis
- •Fungal and Parasitic Infections of the Eyelid Margin
- •Bacterial Conjunctivitis in Children and Adults
- •Parinaud Oculoglandular Syndrome
- •Microbial and Parasitic Infections of the Cornea and Sclera
- •Contact Lens–Related Infectious Keratitis
- •Bacterial Keratitis
- •Atypical Mycobacteria
- •Fungal Keratitis
- •Acanthamoeba Keratitis
- •Corneal Stromal Inflammation Associated With Systemic Infections
- •Microsporidiosis
- •Loiasis
- •Microbial Scleritis
- •6 Ocular Immunology
- •Overview of the Ocular Surface Immune Response
- •Tear Film
- •Immunoregulation of the Ocular Surface
- •Angiogenesis and Lymphangiogenesis in the Cornea
- •Tissue-Specific Patterns of Immune-Mediated Ocular Disease
- •Conjunctiva
- •Cornea
- •Sclera
- •Diagnostic Approach to Immune-Mediated Ocular Disorders
- •Immune-Mediated Diseases of the Eyelid
- •Contact Dermatoblepharitis
- •Atopic Dermatitis
- •Immune-Mediated Disorders of the Conjunctiva
- •Hay Fever Conjunctivitis and Perennial Allergic Conjunctivitis
- •Vernal Keratoconjunctivitis
- •Atopic Keratoconjunctivitis
- •Ligneous Conjunctivitis
- •Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
- •Mucous Membrane Pemphigoid
- •Ocular Graft-vs-Host Disease
- •Other Immune-Mediated Diseases of the Skin and Mucous Membranes
- •Immune-Mediated Diseases of the Cornea
- •Thygeson Superficial Punctate Keratitis
- •Interstitial Keratitis Associated With Infectious Diseases
- •Reactive Arthritis
- •Cogan Syndrome
- •Marginal Corneal Infiltrates Associated With Blepharoconjunctivitis
- •Peripheral Ulcerative Keratitis Associated With Systemic Immune-Mediated Diseases
- •Mooren Ulcer
- •Corneal Transplant Rejection
- •Immune-Mediated Diseases of the Episclera and Sclera
- •Episcleritis
- •Scleritis
- •8 Clinical Approach to Neoplastic Disorders of the Conjunctiva and Cornea
- •Approach to the Patient With a Neoplastic Conjunctival Lesion
- •Management of Patients With Conjunctival Tumors
- •Surgical Treatment
- •Topical Chemotherapy
- •Tumors of Epithelial Origin
- •Benign Epithelial Tumors
- •Preinvasive Epithelial Lesions
- •Malignant Epithelial Lesions
- •Management of Atypical Epithelial Tumors
- •Other Malignant Epithelial Lesions
- •Glandular Tumors of the Conjunctiva
- •Oncocytoma
- •Sebaceous Gland Carcinoma
- •Tumors of Neuroectodermal Origin
- •Benign Pigmented Lesions
- •Preinvasive Pigmented Lesions
- •Malignant Pigmented Lesions
- •Neurogenic and Smooth-Muscle Tumors
- •Vascular and Mesenchymal Tumors
- •Benign Tumors
- •Malignant Tumors
- •Lymphatic and Lymphocytic Tumors
- •Lymphangiectasia and Lymphangioma
- •Lymphoid Hyperplasia
- •Lymphoma
- •Metastatic Tumors
- •9 Basic and Clinical Concepts of Congenital Anomalies of the Cornea, Sclera, and Globe
- •Developmental Anomalies of the Globe and Sclera
- •Cryptophthalmos
- •Microphthalmos
- •Nanophthalmos
- •Blue Sclera
- •Developmental Anomalies of the Anterior Segment
- •Anomalies of Size and Shape of the Cornea
- •Abnormalities of Corneal Structure and/or Clarity
- •Secondary Abnormalities Affecting the Fetal Cornea
- •Intrauterine Keratitis: Bacterial and Syphilitic
- •Congenital Corneal Keloid
- •Congenital Corneal Anesthesia
- •Congenital Glaucoma
- •Birth Trauma
- •Arcus Juvenilis
- •10 Corneal Dystrophies and Ectasias
- •Corneal Dystrophies
- •Epithelial and Subepithelial Dystrophies
- •Bowman Layer Corneal Dystrophies
- •Stromal Corneal Dystrophies: TGFBI Dystrophies
- •Stromal Dystrophies: Non-TGFBI Dystrophies
- •Endothelial Dystrophies
- •Ectatic Disorders
- •Keratoconus
- •Pellucid Marginal Degeneration
- •Keratoglobus
- •11 Systemic Disorders With Corneal Changes
- •Disorders of Carbohydrate Metabolism
- •Mucopolysaccharidoses
- •Diabetes Mellitus
- •Disorders of Lipid Metabolism and Storage
- •Hyperlipoproteinemias
- •Hypolipoproteinemias
- •Sphingolipidoses
- •Mucolipidoses
- •Disorders of Amino Acid Metabolism
- •Cystinosis
- •Tyrosinemia
- •Alkaptonuria
- •Disorders of Protein Metabolism
- •Amyloidosis
- •Disorders of Immunoglobulin Synthesis
- •Noninflammatory Disorders of Connective Tissue
- •Ehlers-Danlos Syndrome
- •Marfan Syndrome
- •Disorders of Nucleotide Metabolism
- •Gout
- •Porphyria
- •Disorders of Mineral Metabolism
- •Wilson Disease
- •Hypercalcemia
- •Hemochromatosis
- •Corneal and External Disease Signs of Systemic Neoplasia
- •Enlarged Corneal Nerves
- •Appendix
- •12 Clinical Approach to Depositions and Degenerations of the Conjunctiva, Cornea, and Sclera
- •Degenerative Changes of the Conjunctiva
- •Age-Related (Involutional) Changes
- •Pinguecula
- •Pterygium
- •Conjunctival Concretions
- •Conjunctival Inclusion Cysts
- •Conjunctivochalasis
- •Conjunctival Vascular Tortuosity and Hyperemia
- •Degenerative Changes in the Cornea
- •Age-Related (Involutional) Changes
- •Epithelial and Subepithelial Degenerations
- •Stromal Degenerations
- •Endothelial Degenerations
- •Scleral Degenerations
- •Drug-Induced Deposition and Pigmentation
- •Corneal Epithelial Deposits
- •Stromal and Descemet Membrane Pigmentation
- •Endothelial Manifestations
- •13 Clinical Aspects of Toxic and Traumatic Injuries of the Anterior Segment
- •Injuries Caused by Temperature and Radiation
- •Thermal Burns
- •Ultraviolet Radiation
- •Ionizing Radiation
- •Chemical Injuries
- •Alkali Burns
- •Acid Burns
- •Management of Chemical Injuries
- •Toxic Keratoconjunctivitis From Medications
- •Pathogenesis
- •Clinical Presentation
- •Management
- •Animal and Plant Substances
- •Insect Injuries
- •Vegetation Injuries
- •Concussive Trauma
- •Subconjunctival Hemorrhage
- •Corneal Changes
- •Traumatic Mydriasis and Miosis
- •Traumatic Iritis
- •Iridodialysis and Cyclodialysis
- •Traumatic Hyphema
- •Nonperforating Mechanical Trauma
- •Conjunctival Laceration
- •Conjunctival Foreign Body
- •Corneal Foreign Body
- •Corneal Abrasion
- •Perforating Trauma
- •Evaluation
- •Management
- •Surgical Trauma
- •Corneal Epithelial Changes From Intraocular Surgery
- •Descemet Membrane Changes During Intraocular Surgery
- •Corneal Endothelial Changes From Intraocular Surgery
- •Conjunctival and Corneal Changes From Extraocular Surgery
- •14 Treatment of Ocular Surface Disorders
- •Surgical Procedures of the Ocular Surface
- •Limbal Transplantation
- •Autologous Conjunctival Transplantation
- •Pterygium Excision
- •Mucous Membrane Grafting
- •Conjunctival Flap
- •Conjunctival Biopsy
- •Conjunctivochalasis Excision
- •Therapeutic Interventions for Corneal Disease
- •Superficial Keratectomy and Corneal Biopsy
- •Management of Descemetocele, Corneal Perforation, and Corneal Edema
- •Corneal Tattoo
- •Tarsorrhaphy
- •15 Clinical Approach to Corneal Transplantation
- •Corneal Transplantation
- •Eye Banking and Donor Selection
- •Criteria Contraindicating Donor Cornea Use
- •Surgical Approach to Corneal Disease
- •Preoperative Evaluation and Preparation
- •Penetrating Keratoplasty
- •Surgical Technique for Penetrating Keratoplasty
- •Combined Procedures
- •Intraoperative Complications
- •Postoperative Care and Complications
- •Control of Postoperative Corneal Astigmatism and Refractive Error
- •Diagnosis and Management of Graft Rejection
- •Pediatric Corneal Transplantation
- •Corneal Autograft Procedures
- •Keratoprosthesis
- •Lamellar Keratoplasty
- •Anterior Lamellar Transplantation
- •Surgical Technique
- •Postoperative Care and Complications
- •Endothelial Keratoplasty
- •DSEK Surgical Technique and Complications
- •Descemet Membrane Endothelial Keratoplasty
- •Basic Texts
- •Related Academy Materials
- •Requesting Continuing Medical Education Credit
enhance the release of the impregnated calcium. If used at all, scraping should be gentle so as to prevent damage to the Bowman layer. A fibrous pannus may be present along with extensive calcific band keratopathy, especially if silicone oil is responsible, and neither EDTA nor scraping will remove such fibrous tissue. A soft contact lens can be helpful postoperatively until the epithelium has healed. The problem can recur but may not do so for years, at which time the treatment may be repeated. PTK using an excimer laser is not advised as a primary treatment because calcium ablates at a different rate from stroma and thus could produce a severely irregular surface. If residual opacification remains after the initial EDTA chelation, then PTK may be employed.
Jhanji V, Rapuano CJ, Vajpayee RB. Corneal calcific band keratopathy. Curr Opin Ophthalmol. 2011;22(4):283–289.
Stromal Degenerations
White limbal girdle of Vogt
Two forms of the white limbal girdle of Vogt have been described. Type I is a narrow, concentric, whitish superficial band running along the limbus in the palpebral fissure and is generally thought to represent early calcific band keratopathy. A lucid interval appears between the limbus and the girdle. This girdle is a degenerative change of the anterior limiting membrane, with chalklike opacities and small clear areas like the holes in Swiss cheese. Type II consists of small, white, flecklike, and needlelike deposits that are often seen at the nasal and temporal limbus in older patients. No clear interval separates this girdle from the limbus. Histologically, there is epithelial elastotic degeneration of collagen, sometimes with particles of calcium.
Corneal arcus
Corneal arcus, or arcus senilis, is most often an involutional change modified by genetic factors. However, arcus is sometimes indicative of a hyperlipoproteinemia (involving low-density lipoproteins) with elevated serum cholesterol, especially in patients younger than 40 years (see Chapter 11). It can be a prognostic factor for coronary artery disease in this age group. Arcus occurs occasionally as a congenital anomaly (arcus juvenilis), usually involving only a sector of the peripheral cornea not associated with abnormalities of serum lipid.
Arcus is a deposition of lipid in the peripheral corneal stroma. It starts at the inferior and superior poles of the cornea and in the late stages involves the entire circumference. The incidence is 60% in individuals between the ages of 50 and 60; it approaches 100% in individuals older than 80 years. The frequency is higher in the black population. The arcus has a hazy white appearance, a sharp outer border, and an indistinct central border; it is denser superiorly and inferiorly (Fig 12-9). A lucid interval is usually present between the peripheral edge of the arcus and the limbus. The lipid is found to be concentrated mainly in 2 areas of the peripheral corneal stroma: one adjacent to Bowman layer and another near Descemet membrane. Unilateral arcus is a rare condition associated with contralateral carotid artery disease or ocular hypotony. Arcus is also seen in Schnyder corneal dystrophy.
Figure 12-9 Corneal arcus. (Courtesy of Robert W. Weisenthal, MD.)
Crocodile shagreen
Anterior crocodile shagreen, or mosaic degeneration, is a central bilateral corneal opacity at the level of Bowman layer characterized by mosaic, polygonal, gray opacities separated by clear zones. Histologically, the Bowman layer is thrown into ridges and may be calcified. Posterior crocodile shagreen shows similar changes in the deep stroma near Descemet membrane.
Cornea farinata
Cornea farinata, an involutional change, is probably dominantly transmitted. The deep corneal stroma shows many subtle dot-shaped and comma-shaped opacities (Fig 12-10), which are often best seen in retroillumination. The deposits may consist of lipofuscin, a degenerative pigment that appears in some aging cells. The condition does not affect vision and has no clinical significance, except that it is sometimes mistaken for a progressive dystrophy. Pre-Descemet corneal dystrophy is most likely related, but it is unclear whether the conditions are degenerations or dystrophies.
Figure 12-10 Cornea farinata. (Courtesy of Robert W. Weisenthal, MD.)
Polymorphic amyloid degeneration
Polymorphic amyloid degeneration is a bilaterally symmetric, slowly progressive corneal degeneration that appears late in life. The corneal opacities emerge as either stellate flecks in midto deep stroma or irregular filaments. The two forms may occur together, but usually one predominates. These deposits are usually axial, polymorphic, and filamentous. The opacities are gray to white and
somewhat refractile but appear translucent in retroillumination (Fig 12-11). The intervening stroma appears clear, and visual acuity is usually normal. The corneal deposits consist of amyloid and can resemble some of the deposits seen in early lattice corneal dystrophy type 3. There is also an acquired (secondary localized) corneal amyloidosis, which may be associated with corneal inflammation (eg, trachoma, leprosy [Hansen disease], phlyctenulosis) or intraocular disease (eg, uveitis, retinopathy of prematurity) or may be secondary to trauma. Clinically, amyloid deposits in acquired corneal amyloidosis can appear as raised, yellow-pink nodular masses in the cornea or be nonspecific. Conjunctival amyloidosis may also be infiltrative. See the discussion on amyloidosis in Chapter 11. In addition, amyloid deposits of the conjunctiva are described in BCSC Section 4, Ophthalmic Pathology and Intraocular Tumors.
Figure 12-11 Polymorphic amyloid degeneration. (Courtesy of Robert W. Weisenthal, MD.)
Senile furrow degeneration
Senile furrow degeneration is an appearance of peripheral thinning in the lucid interval of a corneal arcus that is seen in older persons. Although slight thinning is occasionally present, it is usually more apparent than real. The epithelium is intact. There is no inflammation, vascularization, or tendency to perforate. Vision is rarely affected. No treatment is required.
Terrien marginal degeneration
The cause of Terrien marginal degeneration is unknown. This condition is a quiet, essentially noninflammatory, unilateral or asymmetrically bilateral, slowly progressive thinning of the peripheral cornea. Prevalence is roughly equal between the sexes, and cases usually occur in the second or third decade of life. The corneal thinning can be localized or involve extensive portions of the peripheral cornea.
Terrien marginal degeneration begins superiorly, spreads circumferentially, and in rare cases involves the central cornea or inferior limbus. The central wall is steep, and the peripheral wall slopes gradually. The epithelium remains intact, and a fine vascular pannus traverses the area of stromal thinning. A line of lipid deposits appears at the leading edge of the pannus (central edge of the furrow) (Fig 12-12). Spontaneous perforation is rare, although it can easily occur with minor trauma. Ruptures in Descemet membrane can result in interlamellar fluid or even a corneal cyst. Corneal topography reveals flattening of the peripheral thinned cornea, with steepening of the corneal surface approximately 90° away from the midpoint of the thinned area. This pattern usually results in high against-the-rule or oblique astigmatism.
Figure 12-12 Terrien marginal degeneration with superior thinning. (Courtesy of J. Judelson, MD.)
An inflammatory condition of the peripheral cornea that may resemble Terrien marginal degeneration occurs, in rare instances, in children and young adults. Also known as Fuchs superficial marginal keratitis, it features progressive thinning without epithelial ulceration. It can lead to perforation.
Surgical correction is indicated when perforation is imminent due to progressive thinning or when marked astigmatism significantly limits vision. Crescent-shaped lamellar or full-thickness corneoscleral patch grafts may be used; they have been reported to arrest the progression of severe against-the-rule astigmatism for up to 20 years. Annular lamellar keratoplasty grafts may be required in severe cases of 360° marginal degeneration.
Ceresara G, Migliavacca L, Orzalesi N, Rossetti L. In vivo confocal microscopy in Terrien marginal corneal degeneration: a case report. Cornea. 2011;30(7):820–824.
Keenan JD, Mandel MR, Margolis TP. Peripheral ulcerative keratitis associated with vasculitis manifesting asymmetrically as Fuchs superficial marginal keratitis and Terrien marginal degeneration. Cornea. 2011;30(7):825–827.
Salzmann nodular degeneration
Salzmann nodular degeneration is a noninflammatory corneal degeneration that sometimes occurs as a late sequela to old, long-term keratitis, or it may be idiopathic. Causes include phlyctenulosis, trachoma, and interstitial keratitis. The degeneration may not appear until years after the active keratitis has subsided. It can be bilateral and is more common in middle-aged and older women. The nodules are gray-white or blue-white and elevated (Fig 12-13), and they may be associated with recurrent erosion. They often develop in a roughly circular configuration in the central or paracentral cornea and at the ends of vessels of a pannus. Histologic examination reveals localized replacement of Bowman layer with hyaline and fibrillar material, probably representing basement membrane and material similar to that found in spheroidal degeneration. Confocal microscopy reveals elongated basal epithelial cells and activated keratocytes in the anterior stroma near the nodules and, occasionally, subbasal nerves and tortuous stromal nerve bundles. Treatment for mild cases is lubrication, although manual superficial keratectomy may be indicated in more severe cases (those causing decreased vision secondary to irregular astigmatism). This degeneration may recur after removal.
Roszkowska AM, Aragona P, Spinella R, Pisani A, Puzzolo D, Micali A. Morphologic and confocal investigation on Salzmann nodular degeneration of the cornea. Invest Ophthalmol Vis Sci. 2011;52(8):5910–5919.
Figure 12-13 A, Salzmann nodule in the paracentral cornea. B, Slit-lamp biomicroscopy showing an elevated nodule. C,
View of the lesion using fluorescein dye and a cobalt blue filter. (Courtesy of Cornea Service, Paulista School of Medicine, Federal University of São Paulo.)
Corneal keloid
Corneal keloids are white, superficial, and sometimes protuberant glistening corneal masses that can eventually involve the entire corneal surface. They are thought to be secondary to a vigorous fibrotic response to corneal injury or chronic ocular surface inflammation. Keloids can be congenital or primary, and they have been reported in association with many congenital conditions, such as Lowe syndrome. They have sometimes been confused with hypertrophic scars, Salzmann degeneration, or dermoids. Treatment of symptomatic patients may include superficial keratectomy or penetrating or lamellar keratoplasty.
Vanathi M, Panda A, Kai S, Sen S. Corneal keloid. Ocul Surf. 2008;6(4):186–198.
Lipid keratopathy
In lipid keratopathy, yellow or cream-colored lipids containing cholesterol, neutral fats, and glycoproteins are deposited in the superficial or deeper cornea, usually after prolonged corneal inflammation with scarring and corneal vascularization (eg, herpes simplex or herpes zoster keratitis, trachoma). This form is best described as secondary lipid keratopathy (Fig 12-14). In rare instances, lipid keratopathy has been reported with no evidence of an antecedent infection, inflammatory process, or corneal damage. These cases are best described as primary lipid keratopathy. Treatment is indicated in cases of compromised cosmetic appearance or decreased vision. This keratopathy should be differentiated from Schnyder corneal dystrophy, a rare autosomal dominant stromal dystrophy that is characterized by bilateral corneal opacification resulting from an abnormal accumulation of cholesterol and lipid. Argon laser treatment with and without fluorescein, photodynamic therapy with verteporfin, and subconjunctival and topical bevacizumab have been reported to reduce corneal neovascularization and lipid deposition.
